EyePoint Pharmaceuticals
EYPT
#5849
Rank
โ‚น98.82 B
Marketcap
โ‚น1,184
Share price
-4.29%
Change (1 day)
137.51%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -โ‚น18.57 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น42.34 Million. In 2024 the company made an earning of -โ‚น13.45 Billion a decrease over its 2023 earnings that were of -โ‚น6.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น18.57 Billion38.03%
2024 -โ‚น13.45 Billion104.29%
2023 -โ‚น6.59 Billion-29.88%
2022 -โ‚น9.39 Billion87.2%
2021 -โ‚น5.02 Billion38.58%
2020 -โ‚น3.62 Billion-24.56%
2019 -โ‚น4.8 Billion
2017 -โ‚น2.19 Billion22.59%
2016 -โ‚น1.79 Billion-8.02%
2015 -โ‚น1.95 Billion-296.09%
2014 โ‚น0.98 B-174.02%
2013 -โ‚น1.34 Billion37.42%
2012 -โ‚น0.98 Billion-56.29%
2011 -โ‚น2.23 Billion-1062.38%
2010 โ‚น0.23 B-250.43%
2009 -โ‚น0.16 Billion-89.5%
2008 -โ‚น1.47 Billion
2005 -โ‚น0.91 Billion56.99%
2004 -โ‚น0.58 Billion73.7%
2003 -โ‚น0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-98.99% Bahamas
NRC Health
NRC
โ‚น2.61 B-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA